View in EDS HTML Full Text PDF Full Text

Immune recovery markers in a double blind clinical trial comparing dolutegravir and raltegravir based regimens as initial therapy (SPRING-2).

Saved in:
Bibliographic Details
Title: Immune recovery markers in a double blind clinical trial comparing dolutegravir and raltegravir based regimens as initial therapy (SPRING-2).
Authors: Blanco, Jose-Ramon1 (AUTHOR), Alejos, Belen2 (AUTHOR) balejos@isciii.es, Moreno, Santiago3 (AUTHOR)
Source: PLoS ONE. 1/16/2020, Vol. 15 Issue 1, p1-11. 11p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 141241032
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Immune recovery markers in a double blind clinical trial comparing dolutegravir and raltegravir based regimens as initial therapy (SPRING-2).
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Blanco%2C+Jose-Ramon%22">Blanco, Jose-Ramon</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Alejos%2C+Belen%22">Alejos, Belen</searchLink><relatesTo>2</relatesTo> (AUTHOR)<i> balejos@isciii.es</i><br /><searchLink fieldCode="AR" term="%22Moreno%2C+Santiago%22">Moreno, Santiago</searchLink><relatesTo>3</relatesTo> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22PLoS+ONE%22">PLoS ONE</searchLink>. 1/16/2020, Vol. 15 Issue 1, p1-11. 11p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=141241032
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1371/journal.pone.0226724
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 11
        StartPage: 1
    Titles:
      – TitleFull: Immune recovery markers in a double blind clinical trial comparing dolutegravir and raltegravir based regimens as initial therapy (SPRING-2).
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Blanco, Jose-Ramon
      – PersonEntity:
          Name:
            NameFull: Alejos, Belen
      – PersonEntity:
          Name:
            NameFull: Moreno, Santiago
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 16
              M: 01
              Text: 1/16/2020
              Type: published
              Y: 2020
          Identifiers:
            – Type: issn-print
              Value: 19326203
          Numbering:
            – Type: volume
              Value: 15
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: PLoS ONE
              Type: main
ResultId 1